Posted on
8538
Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.